title: The impact of market volatility on the cell therapy industry.
abstract: Stock market volatility in the cell therapy industry has greatly hindered the investment necessary to fund translational therapies. Here, we review the volatility of leading companies and suggest that a distinct industry is maturing to a point at which the volatility should subside, providing a more attractive environment for future growth.
authors: The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK. david_brindley@harvard.edu
authors: David A
authors: DA
authors: Brindley
authors: Brock C
authors: BC
authors: Reeve
authors: William A
authors: WA
authors: Sahlman
authors: Greg A
authors: GA
authors: Bonfiglio
authors: Natasha L
authors: NL
authors: Davie
authors: Emily J
authors: EJ
authors: Culme-Seymour
authors: Chris
authors: C
authors: Mason
mesh_terms: D004345:Drug Industry / Q000191:economics*; D006801:Humans; D040541:Marketing / Q000191:economics*; D033581:Stem Cell Transplantation / Q000191:economics*; D013997:Time Factors; D035501:Uncertainty